HPLC PURITY
98.9%
BATCH
NXG-2026-Q2-003
CJC-1295 — 2mg
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) engineered with a Drug Affinity Complex (DAC) via a lysine linker. The DAC technology enables covalent binding to circulating albumin, extending plasma half-life in preclinical pharmacokinetic models.
Select Size
Quantity
SKU: NXG-CJC-2MG
FOR IN-VITRO RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · PURCHASE REQUIRES RESEARCHER ATTESTATION
Research Mechanism
CJC-1295 binds to GHRH receptors on pituitary somatotrophs in research preparations, stimulating cAMP-mediated signaling cascades. Preclinical studies examine its pharmacokinetic profile and downstream GH/IGF-1 axis modulation in various tissue research models.
This information is provided for research reference only. No claims are made regarding therapeutic efficacy or safety for human use.
